article · 2013
<scp>TOOKAD</scp> ® <scp>S</scp> oluble vascular‐targeted photodynamic ( <scp>VTP</scp> ) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer
Biopsy data, post-treatment dynamic contrast-enhancement MRI at 1 week after VTP and analysis of the safety data have shown that 4 mg/kg TOOKAD(®) Soluble an...
154 citationsDOI: https://doi.org/10.1111/bju.12265